Serotonin Reuptake Inhibitors in Obstructive Sleep Apnea: Associations in People with and without Epilepsy
Purpose. Positive airway pressure remains the gold-standard treatment for OSA, but many are intolerant. The neurotransmitter serotonin is involved in respiratory control. Evidence exists for SRIs in reducing OSA severity in the general population and ictal hypoxemia and seizure-induced respiratory a...
Saved in:
Main Author: | Jocelyn Y. Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Neurology Research International |
Online Access: | http://dx.doi.org/10.1155/2018/7247605 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ankle edema after administration of selective serotonin reuptake inhibitors
by: Konstantinos Kontoangelos, et al.
Published: (2018-06-01) -
Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?
by: Orna Diav-Citrin, et al.
Published: (2012-01-01) -
Selective Serotonin Reuptake Inhibitors and Associated Bleeding Risks: A Narrative and Clinical Review
by: Amber N. Edinoff, et al.
Published: (2022-11-01) -
Are Selective Serotonin Reuptake Inhibitors a Secondary Cause of Low Bone Density?
by: Kim Chau, et al.
Published: (2012-01-01) -
A Look at Commonly Utilized Serotonin Noradrenaline Reuptake Inhibitors (SNRIs) in Chronic Pain
by: Christopher Robinson, et al.
Published: (2022-05-01)